You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Insulin, Short-Acting

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in Minneapolis, Berlin, Toronto (4 mm x 32G pen needle (Nano), 8mm x 31G pen needle (Short))

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • 4 mm x 32G pen needle (Nano)
  • 8mm x 31G pen needle (Short)
  • Minneapolis, Minnesota
  • +2 more
Feb 28, 2022

Intraoperative Complications Trial in Cairo (Rapid-Acting Insulin)

Completed
  • Intraoperative Complications
  • Rapid-Acting Insulin
  • Cairo, Egypt
    Ain-Shams University
Oct 24, 2022

Diabetes, Type 1 Trial (Afrezza, insulin degludec, Rapid-acting Insulin Analog)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Afrezza
  • +3 more
  • (no location specified)
Jun 6, 2023

Topical Insulin in Neurotrophic Keratopathy After Diabetic

Not yet recruiting
  • Corneal Ulcer
  • +2 more
  • rapid acting insulin
  • BaNHA, Egypt
    Benha University
Jul 2, 2023

Healthy Trial in Edmonton (Salbutamol 400mcg, Budesonide/formoterol, Placebo)

Recruiting
  • Healthy
  • Salbutamol 400mcg
  • +2 more
  • Edmonton, Alberta, Canada
    Clinical Physiology Laboratory
Sep 5, 2023

Insulin Pump,Continuous Glucose Monitoring Technology Trial in Guandong (Insulin Glargine, Metformin, Dapagliflozin)

Recruiting
  • Insulin Pump，Continuous Glucose Monitoring Technology
  • Insulin Glargine
  • +3 more
  • Guandong, China
    刘烈华
Nov 7, 2023

Copd Trial in Assiut (SABA SAMA ICS Vs LABA LAMA ICs)

Not yet recruiting
  • Copd
  • SABA SAMA ICS Vs LABA LAMA ICs
  • Assiut, Egypt
    Nermen Mohammed Abuelkassem
Feb 28, 2023

Diabetes, Type 1 Trial in Manchester (FIASP + closed loop device, Insulin aspart (standard of care insulin) + closed loop

Completed
  • Diabetes Mellitus, Type 1
  • FIASP + closed loop device
  • Insulin aspart (standard of care insulin) + closed loop device
  • Manchester, United Kingdom
    Manchester University Hospitals NHS Foundation Trust
Aug 19, 2022

Alzheimer's Disease, Mild Cognitive Impairment Trial in Winston-Salem (Insulin aspart, Placebo)

Completed
  • Alzheimer's Disease
  • Mild Cognitive Impairment
  • Insulin aspart
  • Placebo
  • Winston-Salem, North Carolina
    Wake Forest Baptist Hospital
May 8, 2020

Erythropoiesis Stimulating Agents for Anemia Management in

Completed
  • Anemia of Chronic Kidney Disease
  • +2 more
    • Giza, Egypt
      the Memorial Souad Kafafi University Hospital
    Jan 24, 2023

    Type2diabetes Trial in Nasiriyah, Basrah (Insulin Glargine 100 UNT/ML Pen Injector [Lantus], Saxagliptin 2.5 mg/ Metformin

    Not yet recruiting
    • Type2diabetes
    • Insulin Glargine 100 UNT/ML Pen Injector [Lantus]
    • +2 more
    • Nasiriyah, Thi Qar, Iraq
    • +1 more
    Oct 28, 2023

    Pharmacokinetics, Pharmacodynamics Trial in Chula Vista (I004, NovoLog)

    Recruiting
    • Pharmacokinetics
    • Pharmacodynamics
    • Chula Vista, California
      Amphastar Study Site
    Sep 13, 2022

    Long Acting Insulin in Control of Gestational Diabetes Trial in Cairo (Long acting insulin, multiple dose regimen)

    Completed
    • Long Acting Insulin in Control of Gestational Diabetes Mellitus
    • Long acting insulin
    • multiple dose regimen
    • Cairo, Egypt
      Ain Shams University Maternity Hospital
    Sep 4, 2021

    Diabetes, Pregnancy Complications Trial in Copenhagen (Faster-acting Aspart insulin Fiasp, Control (insulin Novorapid))

    Active, not recruiting
    • Diabetes Mellitus
    • Pregnancy Complications
    • Faster-acting Aspart insulin Fiasp
    • Control (insulin Novorapid)
    • Copenhagen, Denmark
      Center for Pregnant Women with Diabetes, Rigshospitalet
    Oct 25, 2022

    Diabetes, Type 1 Diabetes Trial in Atlanta (Rapid-Acting Insulin, Long acting insulin)

    Completed
    Has Results
    • Diabetes Mellitus
    • Type 1 Diabetes
    • Rapid-Acting Insulin
    • Long acting insulin
    • Atlanta, Georgia
      Children's Healthcare of Atlanta
    Sep 2, 2021

    Cystic Fibrosis-related Diabetes Trial in Pittsburgh (Insulin, Continuous glucose monitor (CGM))

    Recruiting
    • Cystic Fibrosis-related Diabetes
    • Insulin
    • Continuous glucose monitor (CGM)
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center, Center for Diabetes and
    Sep 7, 2022

    Diabetes Trial in Aurora (Detemir)

    Completed
    Has Results
    • Diabetes
    • Aurora, Colorado
      University of Colorado Denver
    Nov 8, 2021

    Diabetes, Type 1 Trial (Lispro)

    Not yet recruiting
    • Diabetes Mellitus, Type 1
    • (no location specified)
    Dec 13, 2022

    Diabetes, Type 2 Trial in Graz (AT278, NovoRapid, Humulin R 500 UNT/ML Injectable Solution)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Graz, Austria
      Clinical Trials Unit, Medical University of Graz
    Mar 3, 2023

    Type 1 Diabetes Trial in Cambridge (CamAPS FX using faster insulin aspart, CamAPS FX using standard insulin aspart)

    Active, not recruiting
    • Type 1 Diabetes Mellitus
    • CamAPS FX using faster insulin aspart
    • CamAPS FX using standard insulin aspart
    • Cambridge, Cambridgeshire, United Kingdom
    • +1 more
    Nov 9, 2022

    Diabetes, Type 2 Trial in Praha 7, Bratislava (Insulin icodec)

    Completed
    • Diabetes Mellitus, Type 2
    • Insulin icodec
    • Praha 7, Czechia
    • +1 more
    Nov 4, 2022

    Type 2 Diabetes Trial in Charlottesville (Control-IQ use in Type 2 Diabetes under basal insulin injections)

    Not yet recruiting
    • Type 2 Diabetes
    • Control-IQ use in Type 2 Diabetes under basal insulin injections
    • Charlottesville, Virginia
      University of Virginia Center for Diabetes Technology
    Sep 5, 2023

    Chronic Kidney Diseases Trial in Cairo (Glargine, normal saline)

    Recruiting
    • Chronic Kidney Diseases
    • Cairo, Egypt
      Ain Shams University
    Jun 6, 2022

    Type 1 Diabetes Trial in Worldwide (Insulin glargine, 300 U/ml, Insulin degludec, 100U/ml, Background therapy: Rapid acting

    Completed
    Has Results
    • Type 1 Diabetes Mellitus
    • Insulin glargine, 300 U/ml
    • +2 more
    • Dallas, Texas
    • +6 more
    Oct 19, 2022

    Type 1 Diabetes Trial in Montréal (Insulin FiAsp, Insulin Aspart, 60-minutes postprandial exercise)

    Recruiting
    • Type 1 Diabetes Mellitus
    • Insulin FiAsp
    • +3 more
    • Montréal, Quebec, Canada
      Institut de recherches cliniques de Montréal
    Mar 8, 2022